Hearken to this text
![MMI’s Symani system for robotic-assisted microsurgeries has tiny instruments operated by a surgeon using OperaAir controllers.](https://www.therobotreport.com/wp-content/uploads/2024/05/MMI-Symani-OperaAir-controllers-and-wristed-instruments-768x499-1.jpeg)
MMI’s Symani system for robotic-assisted microsurgeries has tiny devices operated by a surgeon utilizing OperaAir controllers. | Supply: MMI
MMI at this time introduced the Symani surgical robotics platform’s first scientific instances within the U.S. The 2 robotic-assisted microsurgical procedures have been carried out at Penn Presbyterian Medical Heart’s Division of Orthopaedic Surgical procedure.
Pisa, Italy-based MMI (integrated as Medical Microinstruments) received FDA de novo classification for the Symani Surgical System in April. The corporate‘s system secured a CE mark in 2019 and has racked up almost 1,000 scientific instances within the EU as of final month.
The primary U.S. instances have been reconstructive extremity microsurgeries, MMI stated in a launch.
“In a single case, the group carried out a ‘free bone switch’ process on a affected person who suffered a traumatic harm; the process concerned transferring a phase of bone and pores and skin from their leg to a broken bone of their forearm,” the corporate stated. “The surgical group revascularized the bone phase utilizing the microsurgical robotic to reconnect the tiny blood vessels and facilitate profitable switch.”
“The second case concerned a affected person in danger for a leg amputation attributable to an contaminated knee prosthesis with comfortable tissue deficiency,” MMI continued. “The group repaired the extreme knee wound with muscle and pores and skin from the affected person’s again and robotically reconnected the blood vessels to advertise revascularization.”
MMI CEO Mark Toland referred to as the primary U.S. instances “a paramount milestone within the world growth of the Symani Surgical System, and we’re honored to have been capable of work with Penn Medication, a premiere orthopedic surgical procedure division, to attain it.”
“At the moment marks the start of a brand new period in surgical innovation, as sufferers throughout the nation with circumstances that require complicated microsurgical strategies, akin to extremity reconstruction, autologous breast reconstruction submit most cancers resection and lymphedema restore, will now have expanded entry to remedy choices,” he acknowledged.
MMI designed Symani’s tiny NanoWrist devices to assist entry and suture small, delicate anatomies together with veins, arteries, nerves and lymphatic vessels as small as 0.3mm in diameter. It offers movement scaling and tremor discount to permit exact micro-movements. The articulated wrist options seven levels of freedom that match the human wrist, tremor filtration and movement scaling.
MMI has raised greater than $200 million, together with a $110 million Collection C spherical in February and a $75 million Collection B spherical in 2022.
Editor’s Be aware: This text was syndicated from The Robotic Report’s sibling web site MassDevice.